A biosynthetic alternative to human amniotic membrane for cornea repair—A comparative in‐vitro study

Abstract

Aims/Purpose: We hypothesize that the biosynthetic Symatix membrane (SM) can replace human amniotic membrane (HAM) in ocular surgical applications. Our aim was to test this hypothesis by comparing the performance of limbal epithelial cells (LECs) cultures on the membranes.Methods: SM was manufactured by the Electrospinning Company Ltd using its proprietary Symatix® Technology platform. SM consists of degradable medical grade poly (lactic‐co‐glycolic acid) polymer fibres and sodium hyaluronan. The suturing and fibrin gluing of SM were tested ex‐vivo by simulation on human corneas. LECs from human limbal tissue were used for testing cellular properties namely cell proliferation (scratch wound and Ki‐67 assay), metabolic activity, limbal epithelial cell marker (cytokeratin‐19 (CK‐19)) tight junction formation (zonula occludens‐1 (ZO‐1)), cell‐ECM interaction (fibronectin (FN)), and basement membrane protein expression (laminin) on SM, plastic, HAM, and freeze‐dried amniotic membrane (FDAM).Results: The surgical handleability of SM was equivalent to HAM. Histological studies demonstrated that epithelial cells on SM had the typical tightly apposed, polygonal, corneal epithelial cell morphology. Rapid wound healing occurred on SM within 3 days; Ki‐67 revealed increased progressive proliferation; and improved metabolic activity was found on SM compared to HAM and FDAM. Immunofluorescence studies showed positive expression of CK‐19, collagen‐1 (Col‐1), laminin, ZO‐1, and FN in SM, plastic, and FDAM compared to negative expression of CK‐19 and ZO‐1 and positive expression of collagen‐1 (Col‐1), laminin and FN in HAM. This could indicate that SM is a better substrate for epithelial cell migration, proliferation, and tight junction formation.Conclusions: This data demonstrates that SM can provide a suitable alternative to HAM for surgical application in sight‐restoring operations.